Urogenital Neoplasms  >>  Mifeprex (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mifeprex (mifepristone) / Danco Laboratories
NCT00140478: Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Completed
2
48
US
Mifepristone, RU-486
Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Massachusetts General Hospital, Brigham and Women's Hospital, Georgetown University
Prostate Cancer, Adenocarcinoma of Prostate
06/06
01/08
NCT00505739: Mifepristone for Patients With Endometrial Cancer and LGESS

Completed
2
13
US
Mifepristone, RU-486
M.D. Anderson Cancer Center
Endometrial Cancer
10/07
05/08
NCT00459290: Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Completed
2
24
US
mifepristone
Gynecologic Oncology Group
Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
07/10
07/10

Download Options